Results 161 to 170 of about 151,970 (246)

Molecular Portrait of Autoantigens in Type 1 Diabetes. [PDF]

open access: yesBiomolecules
Kandinov I   +4 more
europepmc   +1 more source

O55. Prevalence of Autoantibodies to Hmgcr in Myositis Patients [PDF]

open access: bronze, 2014
Zoë Betteridge   +6 more
openalex   +1 more source

Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score

open access: yesEpilepsia, EarlyView.
Abstract Objective This study aimed to identify risk factors and develop a predictive scoring system for autoimmune‐associated epilepsy in subjects with autoimmune encephalitis presenting with new onset refractory status epilepticus (NORSE). Methods This retrospective, multicenter, cohort study included subjects who presented with NORSE at the onset of
Simona Lattanzi   +50 more
wiley   +1 more source

Clinical Characteristics in Swedish Children With and Without Autoantibodies at the Time of Type 1 Diabetes Diagnosis. [PDF]

open access: yesDiabetes Care
Hedlund E   +9 more
europepmc   +1 more source

266 Human autoantibodies from children with movement and psychiatric disorders target the extracellular n-terminus of dopamine-2 receptor [PDF]

open access: gold, 2017
Nese Sinmaz   +8 more
openalex   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes. [PDF]

open access: yesDiabetes Metab Res Rev
Thomas N   +8 more
europepmc   +1 more source

Late‐onset unexplained epilepsy as a risk factor for cognitive impairment and dementia: Protocol for a multi‐center prospective longitudinal observational study (ELUCID)

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Late‐onset unexplained epilepsy (LoUE), defined as epilepsy onset after age 55 without an obvious cause, is an important risk factor for dementia. Studies have shown that 10%–25% of individuals with LoUE develop dementia within 3–4 years following their first seizure.
Alice D. Lam   +13 more
wiley   +1 more source

Autoantibodies in long COVID in a black/mixed population compared with recovered and pre-pandemic controls. [PDF]

open access: yesFront Immunol
de Jesus Silva J   +22 more
europepmc   +1 more source

Severity and Phenotype of Bullous Pemphigoid Relate to Autoantibody Profile Against the NH2- and COOH-Terminal Regions of the BP180 Ectodomain [PDF]

open access: bronze, 2002
Silke Hofmann   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy